2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neutropenia
1
Neurotoxicity Syndromes
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Interventions
Cyclophosphamide
40
fludarabine phosphate
38
Peripheral Blood Stem Cell Transplantation
35
Busulfan
32
Tacrolimus
25
Antilymphocyte Serum
25
Filgrastim
24
Radiotherapy
23
Mycophenolic Acid
23
Methotrexate
22
Cyclosporine
21
Etoposide
18
Methylprednisolone
15
Melphalan
15
Whole-Body Irradiation
14
Cytarabine
13
Cord Blood Stem Cell Transplantation
12
Psychiatric Rehabilitation
11
Therapeutics
10
Flow Cytometry
9
sargramostim
7
Sirolimus
7
Polymerase Chain Reaction
6
Alemtuzumab
6
Thiotepa
5
Granulocyte Colony-Stimulating Factor
5
Carboplatin
5
thymoglobulin
4
ruxolitinib
4
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Lithium Carbonate
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts